Cortactin Phosphorylated by ERK1/2 Localizes to Sites of Dynamic Actin Regulation and Is Required for Carcinoma Lamellipodia Persistence
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Tumor cell motility and invasion is governed by dynamic regulation of the cortical actin cytoskeleton. The actin-binding protein cortactin is commonly upregulated in multiple cancer types and is associated with increased cell migration. Cortactin regulates actin nucleation through the actin related protein (Arp)2/3 complex and stabilizes the cortical actin cytoskeleton. Cortactin is regulated by multiple phosphorylation events, including phosphorylation of S405 and S418 by extracellular regulated kinases (ERK)1/2. ERK1/2 phosphorylation of cortactin has emerged as an important positive regulatory modification, enabling cortactin to bind and activate the Arp2/3 regulator neuronal Wiskott-Aldrich syndrome protein (N-WASp), promoting actin polymerization and enhancing tumor cell movement. METHODOLOGY/PRINCIPAL FINDINGS: In this report we have developed phosphorylation-specific antibodies against phosphorylated cortactin S405 and S418 to analyze the subcellular localization of this cortactin form in tumor cells and patient samples by microscopy. We evaluated the interplay between cortactin S405 and S418 phosphorylation with cortactin tyrosine phosphorylation in regulating cortactin conformational forms by Western blotting. Cortactin is simultaneously phosphorylated at S405/418 and Y421 in tumor cells, and through the use of point mutant constructs we determined that serine and tyrosine phosphorylation events lack any co-dependency. Expression of S405/418 phosphorylation-null constructs impaired carcinoma motility and adhesion, and also inhibited lamellipodia persistence monitored by live cell imaging. CONCLUSIONS/SIGNIFICANCE: Cortactin phosphorylated at S405/418 is localized to sites of dynamic actin assembly in tumor cells. Concurrent phosphorylation of cortactin by ERK1/2 and tyrosine kinases enables cells with the ability to regulate actin dynamics through N-WASp and other effector proteins by synchronizing upstream regulatory pathways, confirming cortactin as an important integration point in actin-based signal transduction. Reduced lamellipodia persistence in cells with S405/418A expression identifies an essential motility-based process reliant on ERK1/2 signaling, providing additional understanding as to how this pathway impacts tumor cell migration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Activation of Arp2/3 complex-mediated actin polymerization by cortactin
Uruno, T., Liu, J., Zhang, P., Fan, Y.-X., Egile, C., Li, R., Mueller, S. C., & Zhan, X. (2001) · Nature Cell Biology · doi:10.1038/35060051 · Cited by 568 · cited 1×
“Biochemical analysis indicates that cortactin interacts directly with the actinrelated (Arp) 2/3 complex through a conserved acidic motif within the amino terminus, initiating Arp2/3-dependent actin nucleation responsible for lamellipodia formation [12,13,14].”
BackgroundTranscriptional Pathway Signatures Predict MEK Addiction and Response to Selumetinib (AZD6244)
Dry, J. R., Pavey, S., Pratilas, C. A., Harbron, C., Runswick, S., Hodgson, D., Chresta, C., McCormack, R., Byrne, N., Cockerill, M., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-1577 · Cited by 262 · cited 1×
“Treatment of UMSCC1 or 1483 cells with the small molecule MEK inhibitor selumetinib [49] reduced EGF-stimulated cortactin S405/418 phosphorylation in a dose-dependent manner, where near elimination of phosphorylation at both serine residues occurred at doses $1 micromolar (Figure 2B).”
BackgroundDu, Y., Weed, S. A., Xiong, W.-C., Marshall, T. D., & Parsons, J. T. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.10.5838 · Cited by 254
Self-citation
Cited by
The Arp2/3 regulatory system and its deregulation in cancer
Molinie, N., & Gautreau, A. (2018) · Physiological Reviews · doi:10.1152/physrev.00006.2017 · Cited by 202
Chen, Y.-K., & Hsueh, Y.-P. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.4405-11.2012 · Cited by 90
“, 2006), and that phosphorylation modulates cortactin function (Huang et al., 1998; Ammer and Weed, 2008; Ren et al., 2009; Kelley et al., 2010), protein phosphorylation may regulate the interaction between cortactin and CTTNBP2.”
BackgroundPKC-Dependent Human Monocyte Adhesion Requires AMPK and Syk Activation
Chang, M.-Y., Huang, D.-Y., Ho, F.-M., Huang, K.-C., & Lin, W.-W. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040999 · Cited by 54
Metadata
- Authors
- Kelley, L. C., Hayes, K. E., Ammer, A. G., Martin, K. H., & Weed, S. A.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2010-11-04
- Volume
- 5
- Issue
- 11
- Pages
- e13847
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W1987769201
- Cited by
- 85
- References
- 3
- FWCI
- 3.54
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cortactin Phosphorylated by ERK1/2 Localizes to Sites of Dynamic Actin Regulation and Is Required for Carcinoma Lamellipodia Persistence. https://app.cochat.ai/papers/10.1371/journal.pone.0013847
- The paper
- Kelley, L. C., Hayes, K. E., Ammer, A. G., Martin, K. H., & Weed, S. A. (2010). Cortactin Phosphorylated by ERK1/2 Localizes to Sites of Dynamic Actin Regulation and Is Required for Carcinoma Lamellipodia Persistence. PLoS ONE. https://doi.org/10.1371/journal.pone.0013847
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.